Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 315

1.

Risk Factors for Liver Function Deterioration after Transarterial Chemoembolization Refractoriness in Child-Pugh Class A Hepatocellular Carcinoma Patients.

Park KH, Kim JH, Choe WH, Kwon SY, Yoo BC, Hwang JH, Park SW, Kim YJ, Park HS, Yu MH, Jeon HJ.

Korean J Gastroenterol. 2020 Mar 25;75(3):147-156. doi: 10.4166/kjg.2020.75.3.147.

PMID:
32209803
2.

Kinetics of nuclear uptake and site-specific DNA cleavage during CRISPR-directed gene editing in solid tumor cells.

Banas K, Rivera-Torres N, Bialk P, Yoo BC, Kmiec EB.

Mol Cancer Res. 2020 Mar 17. pii: molcanres.1208.2019. doi: 10.1158/1541-7786.MCR-19-1208. [Epub ahead of print]

3.

Simultaneous Analysis of Multiple Cancer Biomarkers Using MALDI-TOF Mass Spectrometry Based on a Parylene-Matrix Chip.

Park JM, Kim MJ, Noh JY, Yun TG, Kang MJ, Lee SG, Yoo BC, Pyun JC.

J Am Soc Mass Spectrom. 2020 Mar 24. doi: 10.1021/jasms.9b00102. [Epub ahead of print]

PMID:
32154716
4.

Auxin-dependent control of a plasmodesmal regulator creates a negative feedback loop modulating lateral root emergence.

Sager R, Wang X, Hill K, Yoo BC, Caplan J, Nedo A, Tran T, Bennett MJ, Lee JY.

Nat Commun. 2020 Jan 17;11(1):364. doi: 10.1038/s41467-019-14226-7.

5.

Cas9/gRNA-mediated genome editing of yeast mitochondria and Chlamydomonas chloroplasts.

Yoo BC, Yadav NS, Orozco EM Jr, Sakai H.

PeerJ. 2020 Jan 6;8:e8362. doi: 10.7717/peerj.8362. eCollection 2020.

6.

Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinoma.

Seo JW, Kwan BS, Cheon YK, Lee TY, Shim CS, Kwon SY, Choe WH, Yoo BC, Yoon JM, Lee JH.

Korean J Intern Med. 2020 Jan 10. doi: 10.3904/kjim.2018.062. [Epub ahead of print]

7.

Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth.

Jeoung MH, Kim TK, Kim JW, Cho YB, Na HJ, Yoo BC, Shim H, Song DK, Heo K, Lee S.

Biomolecules. 2019 Nov 1;9(11). pii: E681. doi: 10.3390/biom9110681.

8.

Ginsenosides: the need to move forward from bench to clinical trials.

Yu SE, Mwesige B, Yi YS, Yoo BC.

J Ginseng Res. 2019 Jul;43(3):361-367. doi: 10.1016/j.jgr.2018.09.001. Epub 2018 Sep 7. Review.

9.

Validation of risk prediction tools in elderly patients who initiate dialysis.

Hwang D, Lee E, Park S, Yoo BC, Park S, Choi KJ, Oh S, Kim MJ, Kim H, Jeon JS, Noh H, Han DC, Kwon SH.

Int Urol Nephrol. 2019 Jul;51(7):1231-1238. doi: 10.1007/s11255-019-02160-y. Epub 2019 May 27.

PMID:
31134506
10.

Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment.

Kim AR, Park E, Kwon SY, Park SJ, Kim YJ, Yoo BC, Choe WH, Kim JH, Hwang JH, Park SW, Kim YJ, Park HS, Yu MH, Jeon HJ.

Korean J Gastroenterol. 2019 Mar 25;73(3):167-176. doi: 10.4166/kjg.2019.73.3.167.

11.

Dehydroabietic Acid Suppresses Inflammatory Response Via Suppression of Src-, Syk-, and TAK1-Mediated Pathways.

Kim E, Kang YG, Kim YJ, Lee TR, Yoo BC, Jo M, Kim JH, Kim JH, Kim D, Cho JY.

Int J Mol Sci. 2019 Mar 29;20(7). pii: E1593. doi: 10.3390/ijms20071593.

12.

Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial.

Lim YS, Gwak GY, Choi J, Lee YS, Byun KS, Kim YJ, Yoo BC, Kwon SY, Lee HC.

J Hepatol. 2019 Jul;71(1):35-44. doi: 10.1016/j.jhep.2019.02.021. Epub 2019 Mar 13.

PMID:
30876946
13.

Anti-Wrinkling and Anti-Melanogenic Effect of Pradosia mutisii Methanol Extract.

Lorz LR, Yoo BC, Kim MY, Cho JY.

Int J Mol Sci. 2019 Feb 27;20(5). pii: E1043. doi: 10.3390/ijms20051043.

14.

Prognosis of Spontaneous Bacterial Peritonitis in Hepatocellular Carcinoma Patients.

Kim JH, Choe WH, Kwon SY, Yoo BC.

J Korean Med Sci. 2018 Dec 7;33(52):e335. doi: 10.3346/jkms.2018.33.e335. eCollection 2018 Dec 24.

15.

The Efficacy and Safety of Direct-acting Antiviral Treatment for Chronic Hepatitis C Patients: A Single Center Study.

Park SJ, Kim AR, Choe WH, Kim JH, Yoo BC, Kwon SY.

Korean J Gastroenterol. 2018 Oct 25;72(4):197-204. doi: 10.4166/kjg.2018.72.4.197.

16.

Oxidative Stress-Protective and Anti-Melanogenic Effects of Loliolide and Ethanol Extract from Fresh Water Green Algae, Prasiola japonica.

Park SH, Choi E, Kim S, Kim DS, Kim JH, Chang S, Choi JS, Park KJ, Roh KB, Lee J, Yoo BC, Cho JY.

Int J Mol Sci. 2018 Sep 18;19(9). pii: E2825. doi: 10.3390/ijms19092825.

17.

Individualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcare.

Lee JH, Yu SE, Kim KH, Yu MH, Jeong IH, Cho JY, Park SJ, Lee WJ, Han SS, Kim TH, Hong EK, Woo SM, Yoo BC.

EPMA J. 2018 Aug 17;9(3):287-297. doi: 10.1007/s13167-018-0147-5. eCollection 2018 Sep.

18.

Establishment and Characterization of Paired Primary and Peritoneal Seeding Human Colorectal Cancer Cell Lines: Identification of Genes That Mediate Metastatic Potential.

Kim SC, Hong CW, Jang SG, Kim YA, Yoo BC, Shin YK, Jeong SY, Ku JL, Park JG.

Transl Oncol. 2018 Oct;11(5):1232-1243. doi: 10.1016/j.tranon.2018.07.014. Epub 2018 Aug 14.

19.

Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression.

Cho S, Chae JS, Shin H, Shin Y, Song H, Kim Y, Yoo BC, Roh K, Cho S, Kil EJ, Byun HS, Cho SH, Park S, Lee S, Yeom CH.

Sci Rep. 2018 Jul 27;8(1):11372. doi: 10.1038/s41598-018-29386-7.

20.

A Comparison of Clinical and Radiological Outcomes of Minimally Invasive and Conventional Plate Osteosynthesis for Midshaft Clavicle Fractures.

Kim JY, Yoo BC, Yoon JP, Kang SJ, Chung SW.

Orthopedics. 2018 Sep 1;41(5):e649-e654. doi: 10.3928/01477447-20180711-05. Epub 2018 Jul 16.

PMID:
30011053
21.

Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer.

Park HS, Kim BC, Yeo HY, Kim KH, Yoo BC, Park JW, Chang HJ.

Oncol Rep. 2018 May;39(5):2279-2287. doi: 10.3892/or.2018.6287. Epub 2018 Mar 1.

PMID:
29498404
22.

Src is the primary target of aripiprazole, an atypical antipsychotic drug, in its anti-tumor action.

Kim MS, Yoo BC, Yang WS, Han SY, Jeong D, Song JM, Kim KH, Aravinthan A, Kim JH, Kim JH, Kim SC, Cho JY.

Oncotarget. 2017 Dec 8;9(5):5979-5992. doi: 10.18632/oncotarget.23192. eCollection 2018 Jan 19.

23.

Momordica charantia Inhibits Inflammatory Responses in Murine Macrophages via Suppression of TAK1.

Yang WS, Yang E, Kim MJ, Jeong D, Yoon DH, Sung GH, Lee S, Yoo BC, Yeo SG, Cho JY.

Am J Chin Med. 2018;46(2):435-452. doi: 10.1142/S0192415X18500222. Epub 2018 Feb 20.

PMID:
29463104
24.

Reduced levels of N'-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival.

Kim KH, Joo J, Park B, Park SJ, Lee WJ, Han SS, Kim TH, Hong EK, Woo SM, Yoo BC.

Oncotarget. 2017 Nov 22;8(68):112598-112609. doi: 10.18632/oncotarget.22607. eCollection 2017 Dec 22.

25.

Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14a.

Kim TK, Park CS, Jang J, Kim MR, Na HJ, Lee K, Kim HJ, Heo K, Yoo BC, Kim YM, Lee JW, Kim SJ, Kim ES, Kim DY, Cha K, Lee TG, Lee S.

Mol Oncol. 2018 Mar;12(3):356-372. doi: 10.1002/1878-0261.12169. Epub 2018 Jan 26.

26.

Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis.

Yoo BC, Lee JH, Kim KH, Lin W, Kim JH, Park JB, Park HJ, Shin SH, Yoo H, Kwon JW, Gwak HS.

Oncotarget. 2017 Sep 18;8(60):101203-101214. doi: 10.18632/oncotarget.20983. eCollection 2017 Nov 24.

27.

Is osteoporosis a risk factor for ankle fracture?: Comparison of bone mineral density between ankle fracture and control groups.

Lee DO, Kim JH, Yoo BC, Yoo JH.

Osteoporos Sarcopenia. 2017 Dec;3(4):192-194. doi: 10.1016/j.afos.2017.11.005. Epub 2017 Dec 7.

28.

Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer.

Lee JH, Kim YH, Kim KH, Cho JY, Woo SM, Yoo BC, Kim SC.

Cancer Res Treat. 2018 Jul;50(3):883-893. doi: 10.4143/crt.2017.275. Epub 2017 Sep 18.

29.

Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial.

Yu JI, Park HC, Jung SH, Choi C, Shin SW, Cho SK, Sinn DH, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Yoo BC, Sahinbas H, Paik SW.

Oncotarget. 2017 Apr 13;8(32):52651-52664. doi: 10.18632/oncotarget.17072. eCollection 2017 Aug 8.

30.

Identification of CEA-interacting proteins in colon cancer cells and their changes in expression after irradiation.

Yoo BC, Yeo SG.

Radiat Oncol J. 2017 Sep;35(3):281-288. doi: 10.3857/roj.2017.00255. Epub 2017 Sep 15.

31.

Clinical multi-omics strategies for the effective cancer management.

Yoo BC, Kim KH, Woo SM, Myung JK.

J Proteomics. 2018 Sep 30;188:97-106. doi: 10.1016/j.jprot.2017.08.010. Epub 2017 Aug 15. Review.

PMID:
28821459
32.

Syk Plays a Critical Role in the Expression and Activation of IRAK1 in LPS-Treated Macrophages.

Park JG, Son YJ, Yoo BC, Yang WS, Kim JH, Kim JH, Cho JY.

Mediators Inflamm. 2017;2017:1506248. doi: 10.1155/2017/1506248. Epub 2017 Jun 7.

33.

Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.

Yang WS, Yeo SG, Yang S, Kim KH, Yoo BC, Cho JY.

Amino Acids. 2017 Sep;49(9):1469-1485. doi: 10.1007/s00726-017-2454-x. Epub 2017 Jun 19. Review.

34.

Clinical utility of pretreatment prediction of chemoradiotherapy response in rectal cancer: a review.

Yoo BC, Yeo SG.

EPMA J. 2017 Mar 3;8(1):61-67. doi: 10.1007/s13167-017-0082-x. eCollection 2017 Mar. Review.

35.

SET domain-containing protein 5 is required for expression of primordial germ cell specification-associated genes in murine embryonic stem cells.

Yu SE, Kim MS, Park SH, Yoo BC, Kim KH, Jang YK.

Cell Biochem Funct. 2017 Jul;35(5):247-253. doi: 10.1002/cbf.3269. Epub 2017 Jun 13.

PMID:
28612505
36.

Monotherapy with tenofovir disoproxil fumarate for multiple drug-resistant chronic hepatitis B: 3-year trial.

Lim YS, Lee YS, Gwak GY, Byun KS, Kim YJ, Choi J, An J, Lee HC, Yoo BC, Kwon SY.

Hepatology. 2017 Sep;66(3):772-783. doi: 10.1002/hep.29187. Epub 2017 Jul 18.

PMID:
28370419
37.

Clinical Features of Spontaneous Bacterial Peritonitis: A 10-year Experience from a Single Center.

Na HY, Kim JH, Choe WH, Kwon SY, Yoo BC.

Korean J Gastroenterol. 2017 Feb 25;69(2):129-134. doi: 10.4166/kjg.2017.69.2.129.

38.

Identification of calgranulin B interacting proteins and network analysis in gastrointestinal cancer cells.

Kim KH, Yeo SG, Yoo BC, Myung JK.

PLoS One. 2017 Feb 2;12(2):e0171232. doi: 10.1371/journal.pone.0171232. eCollection 2017.

39.

Therapeutic effects of hyaluronidase on acquired lymphedema using a newly developed mouse limb model.

Roh K, Cho S, Park JH, Yoo BC, Kim WK, Kim SK, Park K, Kang H, Ku JM, Yeom CH, Lee K, Lee S.

Exp Biol Med (Maywood). 2017 Mar;242(6):584-592. doi: 10.1177/1535370216688570. Epub 2017 Jan 16.

40.

Proteins that interact with calgranulin B in the human colon cancer cell line HCT-116.

Myung JK, Yeo SG, Kim KH, Baek KS, Shin D, Kim JH, Cho JY, Yoo BC.

Oncotarget. 2017 Jan 24;8(4):6819-6832. doi: 10.18632/oncotarget.14301.

41.

Long-term real-world entecavir therapy in treatment-naïve hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response.

Cho JY, Sohn W, Sinn DH, Gwak GY, Paik YH, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH.

Korean J Intern Med. 2017 Jul;32(4):636-646. doi: 10.3904/kjim.2016.096. Epub 2016 Nov 4.

42.

Pyrrole-Derivative of Chalcone, (E)-3-Phenyl-1-(2-Pyrrolyl)-2-Propenone, Inhibits Inflammatory Responses via Inhibition of Src, Syk, and TAK1 Kinase Activities.

Yang S, Kim Y, Jeong D, Kim JH, Kim S, Son YJ, Yoo BC, Jeong EJ, Kim TW, Lee IH, Cho JY.

Biomol Ther (Seoul). 2016 Nov 1;24(6):595-603. doi: 10.4062/biomolther.2016.027.

43.

Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.

Lee JH, Yoo BC, Kim YH, Ahn SA, Yeo SG, Cho JY, Kim KH, Kim SC.

BioData Min. 2016 Oct 12;9:32. doi: 10.1186/s13040-016-0111-7. eCollection 2016.

44.

Seven low-mass ions in pretreatment serum as potential predictive markers of the chemoradiotherapy response of rectal cancer.

Roh K, Yeo SG, Yoo BC, Kim KH, Kim SY, Kim MJ.

Anticancer Drugs. 2016 Sep;27(8):787-93. doi: 10.1097/CAD.0000000000000391.

PMID:
27272410
45.

Corrigendum to "Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease" [Atherosclerosis 234 (2) (2014) 270-275].

Sinn DH, Gwak GY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Atherosclerosis. 2016 Jul;250:191. doi: 10.1016/j.atherosclerosis.2016.05.006. Epub 2016 May 10. No abstract available.

PMID:
27177847
46.

Anti-Inflammatory and Antinociceptive Activities of Anthraquinone-2-Carboxylic Acid.

Park JG, Kim SC, Kim YH, Yang WS, Kim Y, Hong S, Kim KH, Yoo BC, Kim SH, Kim JH, Cho JY.

Mediators Inflamm. 2016;2016:1903849. doi: 10.1155/2016/1903849. Epub 2016 Jan 3.

47.

The Role of Protein Arginine Methyltransferases in Inflammatory Responses.

Kim JH, Yoo BC, Yang WS, Kim E, Hong S, Cho JY.

Mediators Inflamm. 2016;2016:4028353. doi: 10.1155/2016/4028353. Epub 2016 Mar 2. Review.

48.

Critical role of protein L-isoaspartyl methyltransferase in basic fibroblast growth factor-mediated neuronal cell differentiation.

Dung TT, Yi YS, Heo J, Yang WS, Kim JH, Kim HG, Park JG, Yoo BC, Cho JY, Hong S.

BMB Rep. 2016 Aug;49(8):437-42.

49.

Antitumor effects of calgranulin B internalized in human colon cancer cells.

Kim K, Kim KH, Roh K, Yoo BC, Ku JL, Shin YK, Cho JY, Kim M, Kwon MH, Goh SH, Chang HJ, Oh JH.

Oncotarget. 2016 Apr 12;7(15):20368-80. doi: 10.18632/oncotarget.7783.

50.

Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial.

Yu JI, Park HC, Oh D, Noh JM, Jung SH, Kim HY, Shin SW, Cho SK, Sinn DH, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25.

PMID:
26915594

Supplemental Content

Support Center